全髋关节置换术治疗髋关节感染后遗症的中远期疗效
本研究回顾性分析94例因髋关节感染后遗症行初次全髋关节置换术的患者,随访(68.3±42.1)个月,Harris髋关节评分从术前(42.1±10.9)分升至末次随访(82.3±11.4)分,10年假体生存率94.7%。病理解剖分型中脱位型和融合型术后功能改善劣于继发骨关节炎型,提示该分型有助于评估手术难度和预测疗效。
要点
- 在感染长期静止前提下,全髋关节置换术可获满意中远期功能改善和假体生存。
- 脱位型和融合型患者术后Harris评分改善程度显著低于继发骨关节炎型。
- 术后总体并发症发生率24.5%,假体周围感染仅1例(1.1%)。
核心结论
- 在感染长期静止前提下,全髋关节置换术治疗髋关节感染后遗症可获得满意的中远期功能改善与假体生存率。
- 髋关节病理解剖分型对手术难度评估与术后疗效预测具有一定指导价值。
研究设计与样本
- 回顾性病例系列研究,纳入2012年1月至2025年1月在新疆医科大学第一附属医院因髋关节感染后遗症行初次全髋关节置换术的94例患者。
- 男性43例,女性51例,年龄(43.5±14.5)岁(范围:18~77岁)。
- 病因包括化脓性髋关节炎后遗症42例、髋关节结核后遗症45例、髋关节骨髓炎后遗症7例。
- 感染静止期为(25.8±14.9)年(范围:0.3~64.0年)。
- 根据病理解剖特点分为继发骨关节炎型(47例)、脱位型(21例)及融合型(26例)。
主要发现
- 随访时间(68.3±42.1)个月(范围:0~160个月)。
- 术后总体并发症发生率为24.5%(23/94),包括假体周围感染1例(1.1%)、无菌性假体松动1例(1.1%)、假体脱位1例(1.1%)、髋关节持续疼痛2例(2.1%)。
- 其他并发症包括神经损伤3例(3.2%)、急性肝功能损伤3例(3.2%)、下肢深静脉血栓9例(9.6%),对症治疗后均恢复正常。
- 末次随访Harris髋关节评分由术前(42.1±10.9)分升至(82.3±11.4)分(t=-29.492,P<0.01)。
- 多因素线性回归显示,与继发骨关节炎型相比,脱位型(β=-7.900,95%CI:-14.909~-0.891,P=0.028)和融合型(β=-9.521,95%CI:-15.540~-3.502,P=0.002)患者术后Harris评分改善更差。
关键数值与推荐
- 假体生存时间为(153.1±3.4)个月(95%CI:146.4~159.7个月),10年生存率为94.7%。
- 脱位型、融合型及继发骨关节炎型患者的假体累积生存率差异无统计学意义(P=0.078)。
临床怎么用
- 对于感染长期静止的髋关节感染后遗症患者,全髋关节置换术可显著改善髋关节功能并获得良好假体生存。
- 术前根据病理解剖分型(继发骨关节炎型、脱位型、融合型)可预判术后功能改善程度,脱位型和融合型改善相对较差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the medium- to long-term outcomes of total hip arthroplasty (THA) for the treatment of sequelae of hip infection. Methods: A retrospective case series analysis was conducted on 94 patients who underwent primary THA for sequelae of hip infection at the Department of Orthopaedics, the First Affiliated Hospital of Xinjiang Medical University from January 2012 to January 2025. There were 43 males and 51 females, with an age of (43.5±14.5) years(range:18 to 77 years). The etiologies included 42 cases of sequelae of suppurative hip arthritis, 45 cases of sequelae of hip tuberculosis, and 7 cases of sequelae of hip osteomyelitis. The quiescent period of infection was (25.8±14.9) years (range:0.3 to 64.0 years). Based on pathoanatomical characteristics, patients were classified into three types: secondary osteoarthritis type (47 cases), dislocation type (21 cases), and ankylosis type (26 cases). Outcome measures included Harris hip score (HHS), complications, and prosthesis survival. Multivariable linear regression was used to identify factors influencing the improvement in HHS. Prosthesis survival was analyzed using the Kaplan-Meier method, and comparisons between groups were performed using the Log-rank test. Results: The follow-up duration was (68.3±42.1) months (range:0 to 160 months). The overall postoperative complication rate was 24.5% (23/94), including periprosthetic joint infection in 1 case (1.1%), aseptic loosening in 1 case (1.1%), prosthetic dislocation in 1 case (1.1%), and persistent hip pain in 2 cases (2.1%). Other complications included nerve injury in 3 cases (3.2%), acute liver injury in 3 cases (3.2%), and deep vein thrombosis in 9 cases (9.6%), all of which resolved with symptomatic treatment. At the final follow-up, the HHS increased from 42.1±10.9 preoperatively to 82.3±11.4 postoperatively (t=-29.492, P<0.01). Multivariable linear regression showed that pathoanatomical classification was independently associated with the degree of HHS improvement. Compared with the secondary osteoarthritis type, patients with the dislocation type (β=-7.900, 95%CI:-14.909 to -0.891, P=0.028) and the ankylosis type (β=-9.521, 95%CI:-15.540 to -3.502, P=0.002) had significantly less improvement in HHS after THA. Kaplan-Meier analysis revealed a prosthesis survival time of (153.1±3.4) months (95%CI: 146.4 to 159.7 months) and a 10-year survival rate of 94.7%. There was no significant difference in cumulative prosthesis survival among the dislocation type, ankylosis type, and secondary osteoarthritis type (P=0.078). Conclusions: Under the premise of a long quiescent period of infection, THA for sequelae of hip infection can achieve satisfactory medium- to long-term functional improvement and prosthesis survival. The pathoanatomical classification of the hip provides some guidance for assessing surgical difficulty and predicting postoperative outcomes. 目的: 探讨全髋关节置换术(THA)治疗髋关节感染后遗症的中远期临床效果。 方法: 本研究为回顾性病例系列研究。回顾性分析2012年1月至2025年1月因髋关节感染后遗症在新疆医科大学第一附属医院接受初次THA治疗的94例患者资料。男性43例,女性51例,年龄(43.5±14.5)岁(范围:18~77岁)。化脓性髋关节炎后遗症42例,髋关节结核后遗症45例,髋关节骨髓炎后遗症7例。感染静止期为(25.8±14.9)年(范围:0.3~64.0年)。根据髋关节病理解剖特点将患者分为继发骨关节炎型(47例)、脱位型(21例)及融合型(26例)。收集患者术后Harris髋关节评分(HHS)、并发症及假体生存情况。采用多因素线性回归分析术后HHS改善量的影响因素。采用Kaplan-Meier法分析假体生存率,组间比较采用Log-rank检验。 结果: 94例患者随访时间(68.3±42.1)个月(范围:0~160个月),患者术后总体并发症发生率为24.5%(23/94),其中发生假体周围感染1例(1.1%),无菌性假体松动1例(1.1%),假体脱位1例(1.1%),髋关节持续疼痛2例(2.1%);其他并发症包括神经损伤3例(3.2%),急性肝功能损伤3例(3.2%),下肢深静脉血栓9例(9.6%),予药物对症治疗后均恢复正常。末次随访时HHS由术前的(42.1±10.9)分升至(82.3±11.4)分(t=-29.492,P<0.01)。多因素线性回归结果显示,病理解剖分型与HHS改善程度独立相关,与继发骨关节炎型相比,脱位型(β=-7.900,95%CI:-14.909~-0.891,P=0.028)和融合型(β=-9.521,95%CI:-15.540~-3.502,P=0.002)的患者THA术后HHS改善更差。Kaplan-Meier生存分析结果显示,患者假体生存时间为(153.1±3.4)个月(95%CI:146.4~159.7个月),10年生存率为94.7%;脱位型、融合型及继发骨关节炎型患者的假体累积生存率差异无统计学意义(P=0.078)。 结论: 在感染长期静止的前提下,THA治疗髋关节感染后遗症可获得满意的中远期功能改善与假体生存率。髋关节病理学解剖分型对手术难度评估与术后疗效预测具有一定指导价值。.
引用
- Chen Q, Li YC, Guo XB, et al. [Medium- to long-term outcomes of total hip arthroplasty for sequelae of hip infection]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 42509223. doi:10.3760/cma.j.cn112139-20260506-00179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。